ociated with the 
transportation of radiotracers. This can help improve patient 
care by allowing more patients to have access to the benefits 
of PET imaging. Major technological breakthroughs were achieved in the 
diagnosis of coronary heart disease through PET. IBAs 70MeV 
cyclotron enables the production of Rubidium-82, while the 
CycloneKIUBE produces 13N-Ammonia both are used for 
non-invasive myocardial perfusion tests. 18
IBA
CORPORATE BROCHURE 2024